Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Exothera
Sort By
Newest First
Sign in
1 / 1
1 / 1
Changing Roles
How are Advancements in Technology Reshaping the Roles and Capabilities of CDMOs and CROs in the Drug Development Life Cycle?
Pharma's Almanac
PAO-08-24-RT-01
Aug 07, 2024
RNA Manufacturing
Exothera Nucleic Acids will be the World’s First CDMO with Access to Quantoom’s Revolutionary Nfinity™ Platform for the continuous production of RNA which Exothera will offer as a service.
Exothera
PR-M04-23-01
Apr 19, 2023
GMP Certification
GMP Certification for Exothera Further Extends its Viral Vector Manufacturing Capacity
Exothera
PR-M03-22-10
Mar 23, 2022
Scale-Up Collaboration
IDT Biologika Collaborates with Exothera to Push Forward the Scale-Up of Viral Vaccines
IDT Biologika
PR-M03-22-01
Mar 01, 2022
